Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome01:13

The Proteasome

1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
The Proteasome02:18

The Proteasome

9.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.3K
The Proteasome02:18

The Proteasome

3.8K
3.8K
The Proteasome Structure01:17

The Proteasome Structure

1.1K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

8.0K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.0K
Regulated Protein Degradation02:58

Regulated Protein Degradation

2.7K
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors.

Journal of medicinal chemistry·2026
Same author

μMap Photoproximity Labeling Enables Small Molecule Binding Site Mapping.

Journal of the American Chemical Society·2023
Same author

Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold.

ACS chemical biology·2022
Same author

μMap-Red: Proximity Labeling by Red Light Photocatalysis.

Journal of the American Chemical Society·2022
Same author

Highly Selective β-Mannosylations and β-Rhamnosylations Catalyzed by Bis-thiourea.

Journal of the American Chemical Society·2020
Same author

Microenvironment mapping via Dexter energy transfer on immune cells.

Science (New York, N.Y.)·2020

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.8K

Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms.

Frances P Rodriguez-Rivera1, Samuel M Levi2

  • 1Discovery Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States.

ACS Central Science
|August 4, 2021
PubMed
Summary

Small molecule degraders offer new therapeutic options by catalytically destroying target proteins. This study introduces a framework to understand and design efficient protein degraders for drug discovery.

More Related Videos

Reporter-based Growth Assay for Systematic Analysis of Protein Degradation
07:47

Reporter-based Growth Assay for Systematic Analysis of Protein Degradation

Published on: November 6, 2014

10.9K
Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
09:57

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

6.8K

Related Experiment Videos

Last Updated: Oct 25, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.8K
Reporter-based Growth Assay for Systematic Analysis of Protein Degradation
07:47

Reporter-based Growth Assay for Systematic Analysis of Protein Degradation

Published on: November 6, 2014

10.9K
Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
09:57

Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach

Published on: December 17, 2016

6.8K

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Biochemistry

Background:

  • Traditional drug discovery focuses on target inhibition, limiting therapeutic options.
  • Proteasomal protein degradation represents a novel therapeutic modality with unique pharmacological profiles.
  • Small molecule degraders can catalytically eliminate target proteins at substoichiometric concentrations, enhancing efficacy and reducing dosage.

Purpose of the Study:

  • To introduce a unifying framework for understanding catalytic protein degradation.
  • To evaluate different degradation modes from a kinetic and catalytic perspective.
  • To guide the rational design and screening of efficient small molecule degraders.

Main Methods:

  • Development of the induced cooperativity spectrum concept.
  • Analysis of published molecular degraders, including molecular glues and bivalent degraders.
  • Mechanistic evaluation of catalytic degradation profiles.

Main Results:

  • The induced cooperativity spectrum provides a holistic framework for understanding catalytic degradation.
  • Key examples illustrate the application of this framework across various degrader types.
  • The framework highlights the importance of kinetically favored degradation mechanisms.

Conclusions:

  • A mechanistic understanding of catalytic degradation is crucial for advancing drug discovery.
  • The induced cooperativity spectrum offers a novel approach to designing efficient protein degraders.
  • Further research is needed to address challenges and explore opportunities in degrader development.